1429-25-0

Basic information

• Product Name: 4H-Pyran-4-one,3-hydroxy-6-(hydroxymethyl)-2-(4-morpholinylmethyl)-
• Synonyms: 4H-Pyran-4-one,3-hydroxy-6-(hydroxymethyl)-2-(morpholinomethyl)- (6CI,7CI,8CI); 3-Hydroxy-6-(hydroxymethyl)-2-(4-morpholinylmethyl)-4H-pyran-4-one; 6-(Morpholinylmethyl)kojic acid; NSC 94254
• CAS NO: 1429-25-0
• Molecular Formula: C₁₁H₁₅NO₅
• Molecular Weight: 241.2405
• Mol File: 1429-25-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 469.4°Cat760mmHg
• Flash Point: 237.7°C
• Density: 1.4g/cm³
• CAS DataBase Reference: 4H-Pyran-4-one,3-hydroxy-6-(hydroxymethyl)-2-(4-morpholinylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-Pyran-4-one,3-hydroxy-6-(hydroxymethyl)-2-(4-morpholinylmethyl)-(1429-25-0)
• EPA Substance Registry System: 4H-Pyran-4-one,3-hydroxy-6-(hydroxymethyl)-2-(4-morpholinylmethyl)-(1429-25-0)

Safety Data

• Hazardous Substances Data: 1429-25-0(Hazardous Substances Data)

Usage

Type

Complex organic compound

Structure

Pyran ring with a hydroxyl group at the third position, a hydroxymethyl group at the sixth position, and a morpholinylmethyl group at the second position

Applications

Pharmaceuticals, agrochemicals, material science

Potential

Biological activity, development of new drugs, synthesis of other compounds

Characteristics

Unique structure, potential industrial applications

Interest

Subject of interest for further study

Upstream product

• 110-91-8 morpholine 
• 501-30-4 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one 
• 50-00-0 formaldehyd 

Downstream Products

• 128109-33-1 6-Morpholinomethyl-5-p-methoxybenzyloxy-2-hydroxymethyl-4-pyrone 

Relevant articles and documents

Mannich products of kojic acid and N-heterocycles and their Ru(II)-arene complexes: Synthesis, characterization and stability

Ru(II)-η6-p-cymene compounds bearing pyrone-derived ligands, which were obtained by Mannich reaction with piperidine and related analogues, have been synthesized. The compounds were characterized by NMR spectroscopy, mass spectrometry, thermogr

Cephalosporin compounds and antibacterial agents

Novel cephalosporin compounds represented by formula (I): STR1 wherein R1 represents a lower alkyl group which may optionally have a substituent; each of R2 and R3 independently represents a hydrogen atom or hydroxy group; and A represents a hydrogen atom or a residue of nucleophilic compound, and pharmacologically acceptable salts or esters thereof exhibit a potent antibacterial activity against gram positive and gram negative bacteria.